1 Report Prologue 12
2 Introduction 18
2.1 Scope of Study 18
2.2 Research Objective 18
2.3 Assumptions & Limitations 18
2.3.1 Assumptions 18
2.3.2 Limitations 18
2.4 Market Structure 19
3 Research Methodology 20
3.1 Primary Research 21
3.2 Secondary Research 21
4 Market Dynamics 22
4.1 Drivers 22
4.1.1 Increasing prevalence of Sports Injuries 22
4.1.2 Increasing number of Sports Medicine Associations 23
4.1.3 Increasing Awareness 23
4.1.4 Technological development 23
4.2 Restraints 23
4.2.1 Lack of skilled professionals 23
4.2.2 High cost 23
4.3 Opportunities 24
4.3.1 Rise in influx of athletes 24
4.3.2 Technological advances in sports medicines 24
4.4 Threats 24
4.4.1 Introduction of small and medium sized companies 24
5 Market Factor Analysis 25
5.1 Porters Five Forces Analysis 25
5.1.1 Bargaining Power of Suppliers 26
5.1.2 Bargaining Power of Buyers 26
5.1.3 Threat of New Entrants 26
5.1.4 Threat of Substitutes 26
5.1.5 Intensity of Rivalry 27
6 Global Sports Medicine Market, By Product 28
6.1 Introduction 28
6.1.1 Joint Reconstructive & Repair Products 30
6.1.2 Body Support and recovery products 31
6.1.3 Accessories 32
7 Global Sports Medicines Market, By Application 33
7.1 Introduction 33
7.1.1 Shoulder Treatment 35
7.1.2 Knee Treatment 36
7.1.3 Hip Treatment 37
7.1.4 Spine Treatment 38
8 Global Sports Medicines Market, by Procedures 39
8.1 Introduction 39
8.1.1 Tendinosis 41
8.1.2 Tendon to Bone 42
8.1.3 Cartilage repair 43
9 Global Sports Medicines Market, By End User 44
9.1 Introduction 44
9.1.1 Hospital & Emergency Care 45
9.1.2 Trauma center 47
9.1.3 Ambulatory Care 48
10 Global Sports Medicine Market, By Region 49
10.1 Introduction 49
10.2 North America 51
10.2.1 Introduction 51
10.2.2 U.S. 55
10.2.3 Canada 57
10.2.4 South America 59
10.3 Europe 62
10.3.1 Introduction 62
10.3.2 Germany 66
10.3.3 France 68
10.3.4 UK 70
10.3.5 Italy 72
10.3.6 Spain 74
10.3.7 Rest of Western Europe 76
10.3.8 Eastern Europe 78
10.4 Asia-Pacific 81
10.4.1 Introduction 81
10.4.2 Japan 84
10.4.3 China 86
10.4.4 India 88
10.4.5 Republic of Korea 90
10.4.6 Australia 92
10.4.7 Rest of Asia Pacific 94
10.5 Middle East & Africa 97
10.5.1 Introduction 97
10.5.2 Middle East 100
10.5.3 Africa 102
11 Company Landscape 104
11.1 Introduction 104
12 Company Profile 107
12.1 Medtronics 107
12.1.1 Company Overview 107
12.1.2 Product/Business Segment Overview 107
12.1.3 Financial Overview 108
12.1.4 Key Development 109
12.2 Stryker 110
12.2.1 Company Overview 110
12.2.2 Product/Business Segment Overview 110
12.2.3 Financial Overview 111
12.2.4 Key Development 112
12.3 Zimmer Biomet 113
12.3.1 Company Overview 113
12.3.2 Product/Business Segment Overview 113
12.3.3 Financial Overview 114
12.3.4 Key Development 115
12.4 Conmed Corporation 116
12.4.1 Company Overview 116
12.4.2 Product/Business Segment Overview 116
12.4.3 Financial Overview 117
12.4.4 Key Development 118
12.5 DePuy Synthes 119
12.5.1 Company Overview 119
12.5.2 Product/Business Segment Overview 119
12.5.3 Financial Overview 120
12.5.4 Key Development 121
12.6 GE Healthcare 122
12.6.1 Company Overview 122
12.6.2 Product/Business Segment Overview 122
12.6.3 Financial Overview 123
12.6.4 Key Development 124
12.7 Smith & Nephew plc 125
12.7.1 Company Overview 125
12.7.2 Product Overview 125
12.7.3 Financials 126
12.7.4 Key Developments 127
12.8 Arthrex, Inc. 128
12.8.1 Company Overview 128
12.8.2 Product/Business Segment Overview 128
12.8.3 Financial Overview 129
12.8.4 Key Development 129